Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.12.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016

JAMA - Journal of the American Medical Association
Medicine
2016English

Cost-Effectiveness Analysis of Celecoxib in the Treatment of Patients With Chronic Pain in Japan

Iryo To Shakai
2014English

Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients With Chronic Pain

Pain and Therapy
NeurologyAnesthesiologyPain Medicine
2016English

Public Health Impact and Cost Effectiveness of Hepatitis a Vaccination in the United States: A Population-Based Dynamic Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Evaluating Dynamic Impacts of Abuse-Deterrent Prescription Opioid Formulations

Addiction
MedicinePsychiatryMental Health
2018English

A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

Cannabis and Cannabinoid Research
Alternative MedicinePharmacologyComplementary
2019English

Abuse-Deterrent Formulations, an Evolving Technology Against the Abuse and Misuse of Opioid Analgesics

Journal of Medical Toxicology
MutagenesisToxicologyHealth
2012English

Statin Cost Effectiveness in Primary Prevention: A Systematic Review of the Recent Cost-Effectiveness Literature in the United States

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

An Overview of Abuse-Deterrent Opioids and Recommendations for Practical Patient Care

Journal of Multidisciplinary Healthcare
MedicineNursing
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy